Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.530NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.17.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.570NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.633NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DD.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.136NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAYNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DJ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAENWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.467NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.484NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.476NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.19NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.18NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.404NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CV.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DJ.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.73NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DW.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BR.5.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAKNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.42.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.348NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.428.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-14910.4South Korea
AJ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.459NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.29NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.415.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.243.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.98NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.566NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.480NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.579NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
N.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.11 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.435NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.445NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.124NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.384NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAQNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.569NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.524NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
A.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.596.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.473NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used